The experimental therapy tozorakimab from AstraZeneca was superior to a placebo at reducing the rate of moderate to severe exacerbations, or sudden episodes of symptom worsening, in adults with ...

March 27 (Reuters) - AstraZeneca said on Friday its experimental respiratory treatment tozorakimab showed a meaningful ...

Add Yahoo as a preferred source to see more of our stories on Google. A Florence woman told us how a modern COPD treatment at Christ Hospital helped her to be able to do things she couldn't do before.

A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade. In clinical trials, ...

GD analyst, Vinie Varkey notes that tozorakimab could capture a "significant patient share" as an add-on therapy in COPD.

Top-line results from the OBERON and TITANIA trials showed that tozorakimab reduced the annualised rate of moderate-to-severe ...

The rate of new chronic obstructive pulmonary disease (COPD) cases decreased from 2001 to 2020, although the prevalence of COPD has increased.

BATON ROUGE, La. (WAFB) - Around 14 million Americans have diagnosed COPD, but over a million more live without a diagnosis, according to the CDC. Donna Marshall was referred to Dr. Brad Vincent, a ...

NORTH PHILADELPHIA (WPVI) -- There's a potential new treatment for severe emphysema, and Philadelphia is a key test site for this small device with big potential to improve lives. In COPD (Chronic ...

Use of CT is proven to save lives in patients eligible for lung cancer screening, which includes most patients with COPD, said Barr, professor of medicine and epidemiology at Columbia University ...

Please provide your email address to receive an email when new articles are posted on . Smoking abstinence during week 9 to week 12 among adults with COPD was 19.1% with 12-cytisinicline vs. 4.3% with ...